Search

… Job Title Lab Technician

Sign up to receive an email notification when the 2016-2017 Elective Program application is available.

… Fill out the form below if you would like to receive an email notification when the 2016-2017 Elective Program calendar and application is available. All fields are required. We won’t use your personal information for any other purpose.

… Species:  Human Category:  Cancer Tissue of Origin:  Vulva Cancer Type:  Vulvar Leiomyosarcinoma Description SK-LMS-01 is a human vulva cancer cell line. Source This cell line was established from a vulva metastasis in a 43-year-old person with Vulvar Leiomyosarcinoma. Lead Researcher/Research Laboratory

Acupuncturist Jonathan Simon explains the science and theory behind the use of acupuncture for symptom relief.

… MSK acupuncturist Jonathan Simon says that many studies have demonstrated the effectiveness of acupuncture in relieving pain, nausea, anxiety, insomnia, and other side effects of cancer treatment. In acupuncture, a certified practitioner inserts tiny needles through the skin at specific points that are

The FDA has approved the targeted drug repotrectinib for patients 12 and older with tumors that carry gene changes called NTRK fusions. The trial that resulted in the approval was led by MSK investigators.

… Thursday, June 13, 2024 On June 13, 2024, a targeted drug called  repotrectinib (Augtyro TM ) received accelerated approval from the US Food and Drug Administration (FDA) for treating cancers caused by gene changes called  NTRK fusions. The clinical trial that resulted in the approval was led globally

A prostate-specific antigen (PSA) test taken for the first time between the ages of 44 and 50 can predict the likelihood that a man will die from prostate cancer over the next 25 to 30 years, according to researchers at Memorial Sloan Kettering Cancer Center.

… Thursday, May 19, 2011 A prostate-specific antigen (PSA) test taken for the first time between the ages of 44 and 50 can predict the likelihood that a man will die from prostate cancer over the next 25 to 30 years, according to researchers at Memorial Sloan Kettering Cancer Center. The findings, which

… Job Title Graduate Research Assistant

Memorial Sloan Kettering medical oncologist Maria Rubinstein specializes in caring for people with gynecologic cancers, including uterine (endometrial) cancer, cervical cancer, and ovarian cancer.

… Gynecologic Medical Oncologist Job Title Assistant Attending Physician I am a medical oncologist and clinical researcher with a primary focus on caring for people with gynecologic cancers. These include ovarian , uterine (endometrial) , and cervical cancers . As part of a specialized multidisciplinary

La médica oncóloga del Memorial Sloan Kettering Maria Rubinstein se especializa en la atención de personas con cánceres ginecológicos, incluido el cáncer de útero (endometrio), el cáncer cervical y el cáncer de ovario.

… Gynecologic Oncologist Job Title Adjunta asistente Soy médica oncóloga e investigadora clínica y me dedico principalmente al cuidado de personas con cánceres ginecológicos. Estos incluyen cánceres de ovario , de útero (endometrial) y cervical . Como parte de un equipo multidisciplinario especializado

Pituitary adenomas continue to grow in a small subset of patients despite treatment with standard surgery and radiotherapy. Recognizing the significant unmet needs in this cohort, we recently published a review of the latest treatment options.

… Wednesday, October 14, 2020 Pituitary adenomas continue to grow in a small subset of patients despite treatment with standard surgery and radiotherapy. Further treatments may provide symptom relief but are rarely definitive for disease management in this cohort. Recognizing the significant unmet needs